FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)

CUSIP: 31447P100

Q1 2019 13F Holders as of 31 Mar 2019

Holder snapshot 6 signals
Share change
-99,891
SEC-reported price per share
$4.85
Indexed holders
44
Value change
-$525,691
Number of buys
18
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
34,958,098

Security key

31447P100

Report period

Q1 2019

Indexed institutions

44

Top holders

10

Ownership snapshot

Top reported holders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Southpoint Capital Adviso...
Disclosed value leader
Southpoint Capital Adviso...
Comparable rows
0/15
Latest evidence
31 Dec 2018
13F Highest disclosed value: $25,502,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Southpoint Capital Advisors LP has the largest disclosed position value at $25.5M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Southpoint Capital Advisors LP's linked filing trail.
Disclosed position value Top 5
Southpoint Capital Advisors LP $25.5M
Avoro Capital Advisors LLC $7.06M
683 Capital Management, LLC $6.2M
Opaleye Management Inc. $5.74M
EVENTIDE ASSET MANAGEMENT, LLC $4.59M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Southpoint Capital Advisors LP
13F
Company
13F
—
denominator unverified
$25,502,000
3,997,214 shares
— 31 Dec 2018
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$7,056,000
1,105,999 shares
— 31 Dec 2018
683 Capital Management, LLC
13F
Company
13F
—
denominator unverified
$6,197,000
971,351 shares
— 31 Dec 2018
Opaleye Management Inc.
13F
Company
13F
—
denominator unverified
$5,742,000
900,000 shares
— 31 Dec 2018
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$4,594,000
720,000 shares
— 31 Dec 2018
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$3,588,000
562,216 shares
— 31 Dec 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
44
Shares
9,638,104
Indexed holders
44
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 indexed holders
45
Q1 2019 indexed holders
44
Indexed holder difference
-1
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 value Q1 2019 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .